Radiotherapeutisch Instituut Friesland
- Address
- Borniastraat 36, 8934 AD Leeuwarden, The Netherlands
Radiotherapeutisch Instituut Friesland - Advanced Rectal Cancer Treatment Center
The Radiotherapeutisch Instituut Friesland is a specialized radiation therapy center dedicated to advancing organ-preserving treatment strategies for gastrointestinal cancers. The institute focuses on innovative approaches that combine radiotherapy with surgical and systemic treatment options to maximize patient outcomes while maintaining quality of life.
- Organ preservation strategies for early-stage rectal cancer using short- and long-course radiotherapy regimens
- Watchful waiting protocols following radiotherapy in carefully selected rectal cancer patients
- Integration of transanal surgery with radiation therapy for localized colorectal malignancies
The center's research emphasizes organ preservation in patients with early-stage rectal cancer (cT1-3abN0M0) and early-intermediate disease, evaluating the effectiveness of combined treatment modalities. By investigating alternatives to traditional radical surgery, the institute aims to identify patients who can safely avoid major surgical procedures through watchful waiting or minimally invasive transanal surgical approaches following radiotherapy, potentially transforming the standard of care for early rectal cancer management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Amsterdam UMC Stichting2active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amsterdam UMC Stichting3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Radiotherapeutisch Instituut Friesland
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Bintrafusp Alfa Combined with Chemoradiation in Esophageal Squamous Cell Carcinoma: A Feasibility Study | Amsterdam UMC Stichting | Phase II | Not Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Oxaliplatin | 6 | Unknown | 2017-10-09 | 2026-03-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.